1341037-89-5 Usage
General Description
The chemical compound "2-(tert-butoxycarbonyl)-2-azaspiro[4.4]nonane-7-carboxylic acid" is a derivative of the amino acid proline, containing a spirocyclic structure. It is commonly used as a building block in the synthesis of peptides and peptidomimetics. The tert-butoxycarbonyl (Boc) protecting group is often utilized to block the reactivity of the amine group on the proline residue during peptide synthesis, allowing for selective chemical reactions to occur elsewhere on the molecule. 2-(tert-butoxycarbonyl)-2-azaspiro[4.4]nonane-7-carboxylic acid has found application in the development of pharmaceuticals, as well as in biochemical and medicinal research. Due to its unique structure and synthetic flexibility, it is a valuable tool for the creation of new molecules with potential therapeutic or diagnostic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1341037-89-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,1,0,3 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1341037-89:
(9*1)+(8*3)+(7*4)+(6*1)+(5*0)+(4*3)+(3*7)+(2*8)+(1*9)=125
125 % 10 = 5
So 1341037-89-5 is a valid CAS Registry Number.
1341037-89-5Relevant articles and documents
Polycyclic amide derivative as CDK9 inhibitor, and preparation method and application thereof
-
, (2021/07/24)
The invention belongs to the technical field of polycyclic amide derivatives, and particularly relates to a polycyclic amide derivative as a CDK9 inhibitor, and a preparation method and application thereof. The polycyclic amide derivative shows excellent CDK9 enzyme inhibitory activity, and can be used for preparing drugs for treating cancers, especially hematologic cancers including acute myeloid leukemia, multiple myeloma, chronic lymphocytic leukemia, follicular lymphoma and the like and solid tumors, such as acute myeloid leukemia, multiple myeloma, chronic lymphocytic leukemia and follicular lymphoma, including breast cancer, prostate cancer, ovarian cancer, hepatocellular carcinoma, pancreatic cancer, kidney cancer, stomach cancer, colorectal cancer, lung cancer and the like.
